Plate Nº 27 · recorded November 17, 2026
Health & Medicine ResearchReported finding
Colorectal Cancer in Young Adults May Be Biologically Distinct
Colorectal cancer is now the top cancer killer of U.S. adults under 50, and stiffer tissue, unique mutational signatures and worse survival suggest the disease in young people is biologically different.
By Marcus Bennett4 min read853 words
In brief
- Colorectal cancer became the deadliest cancer in U.S. adults under 50, per the American Cancer Society's January 2026 report.
- People born in the 1990s have at least four times the colorectal cancer risk of those born in the 1960s in several countries.
- Two colibactin-linked mutational signatures were over three times more common in colorectal cancer patients under 40.
- The USPSTF lowered the screening start age from 50 to 45 in 2021; patients under 35 have the worst survival.

Colorectal cancer is now the deadliest cancer in Americans under age 50, according to the American Cancer Society's January 2026 annual report — and mounting evidence suggests the disease attacking younger adults may be biologically different from the version doctors have treated for decades.
Painter Reuben Cheatem's case shows the pattern. After a year of symptoms mistaken for food poisoning and diverticulitis, he learned at age 42 in September of his diagnosis year that he had stage III colorectal cancer. He ate well, exercised, avoided carcinogenic oil paints and had no family history. "The cancer diagnosis itself came as a shock because I felt like I had been taking so many steps to simply not get cancer," says Cheatem, who now lives in Texas.
What do the numbers show?
Rates in adults over 65 are falling, but diagnoses in younger people have climbed steadily since the mid-1990s. In 2021 the U.S. Preventive Services Task Force lowered the recommended screening age from 50 to 45. People born in the 1990s carry at least four times the colorectal cancer risk of those born in the 1960s in Australia, Canada and England. Registries in Korea, Japan, Thailand and India report similar rises. Actors James Van Der Beek and Chadwick Boseman both died of the disease in their 40s.
Kimmie Ng, an oncologist who leads the Young-Onset Colorectal Cancer Center at Dana-Farber Cancer Institute, founded in 2019, says her team sees advanced tumors in young patients with no family history who are otherwise healthy.
Why do researchers suspect a new biology?
Diagnosis delays explain part of the problem: a 2018 report found 67 percent of early-onset patients saw at least two physicians before diagnosis. But delays do not explain everything. "Regardless of how they were diagnosed, the survival of the very youngest patients is still worse," Ng says. "That suggests to me that there may be something biologically different."
At the 2025 American Association for Cancer Research meeting, Andrea Cercek of Memorial Sloan Kettering Cancer Center posed the question haunting the field: "Is this a completely new cancer that we're now seeing in young people for whatever reason? Or has there just been this shift that's now happening younger and younger?"
Colon cancer normally follows a 10-to-15-year path from normal cell to polyp to tumor. Cercek's 2021 study found tumors from patients aged 14 to 93 showed no significant genetic differences — the mutations are the same, but something may be accelerating the timeline.
What did the 2025 mutational-signature study find?
Researchers analyzing data from 11 countries on four continents identified two mutational signatures — distinctive DNA damage patterns — more than three times more prevalent in colorectal cancer patients under 40 than in patients 70 and older. These signatures link to colibactin, a toxin produced by pks-positive E. coli gut bacteria, which may damage DNA in the colon's mucus glands. Animal modeling suggests these bacteria colonize hosts in the first decade of life. Ng, who was not involved, cautions that further research must establish how common these bacteria are in children and what effects they carry. A group including Ng's team plans to confirm the findings in a larger U.S. population.
Why are young patients' tumors more dangerous?
Ng's and Cercek's teams independently found that patients diagnosed under 35 die faster than any other age group — worse even than patients in their 60s. Younger patients more often have aggressive signet ring cell carcinoma and tumors on the left colon and rectum, for reasons researchers do not yet understand. Ng has mapped every cell in early-onset tumors for comparison; the study was recently accepted in Nature Medicine.
Separately, Emina Huang of UT Southwestern Medical Center noticed during surgery that young patients' colons felt stiffer. A biomechanical study of 19 patients aged 57–70 and 14 patients aged 42–46 confirmed it: young patients had stiffer tumors — and, strikingly, stiffer normal tissue than older patients. In Advanced Science, her team reported the collagen in younger patients is thicker and more linearly aligned, "easier for the cancer cells to crawl and move," Huang says. The findings point toward possible anti-fibrosis therapies and, eventually, noninvasive tissue-stiffness screening, though that work remains in very early stages.
What could change for screening?
A blood test for colon cancer has FDA approval and American Cancer Society recommendation, though the USPSTF has not endorsed it because it misses very early-stage cancers. "We have to prove that there really is enough reason to make that recommendation to a 15-year-old or a 20-year-old," says Johns Hopkins oncologist Elizabeth Jaffee. Such a test might have caught Cheatem's cancer at stage II, sparing him chemotherapy's side effects — cold sensitivity so severe that "touching something cold was more like sticking your finger in a socket," he recalls. Cercek's verdict on the causes: "Maybe I'll be able to tell you in a couple of years."
For now, the youngest patients keep dying fastest, and the screening net still does not reach them.
via scientificamerican.com (Source)
More from Marcus Bennett
Show full bio
News editor covering regulation, policy and their impact on general science news at SciBeat.
493 articles
Nearby plates
- Most Young Colorectal Cancer Patients Are Diagnosed Late, Study Finds
- Cancer Rising in Younger Adults, and Obesity Alone Cannot Explain It
- Skin Cancer Rates Climb Faster in Women Across Generations, Study Finds
- Age-Based Cancer Genetic Testing Misses 72% of Inherited Variants
- Study of 16 children finds hidden aggressive cells in rhabdomyosarcoma